keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gastric inhibitory peptide 1 (GIP-1) (3-42), a fragment of the incretin hormone GIP and antagonist to the GIP receptor, is generated through the action of serum dipeptidyl peptidase 4 (DDP-4). When administered at 25 nmol/kg to an ob/ob mouse diabetes model, GIP-1 (3-42) elevates plasma glucose levels and lowers plasma insulin levels, demonstrating its effect on reducing insulin secretion from BRIN-BD11 pancreatic cells at a concentration of 100 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 μg | Inquiry | $ 76.00 | |
1 mg | Inquiry | $ 145.00 | |
5 mg | Inquiry | $ 452.00 | |
10 mg | Inquiry | $ 825.00 |
Description | Gastric inhibitory peptide 1 (GIP-1) (3-42), a fragment of the incretin hormone GIP and antagonist to the GIP receptor, is generated through the action of serum dipeptidyl peptidase 4 (DDP-4). When administered at 25 nmol/kg to an ob/ob mouse diabetes model, GIP-1 (3-42) elevates plasma glucose levels and lowers plasma insulin levels, demonstrating its effect on reducing insulin secretion from BRIN-BD11 pancreatic cells at a concentration of 100 nM. |
Synonyms | Glucose-dependent Insulinotropic Polypeptide 3-42, GIP-1 (3-42) |
Molecular Weight | 4749.30 |
Formula | C214H324N58O63S.XCF3COOH |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gastric Inhibitory Peptide 1 (3-42) (human) TFA Glucose-dependent Insulinotropic Polypeptide 3-42 GIP-1 (3-42) inhibitor inhibit